A rapid CRISPR competitive assay for in vitro and in vivo discovery of potential drug targets affecting the hematopoietic system

por Shen, Yunbing, Jiang, Long, Iyer, Vaishnavi Srinivasan, Raposo, Bruno, Dubnovitsky, Anatoly, Boddul, Sanjaykumar V., Kasza, Zsolt, Wermeling, Fredrik
Publicado 2021

Designing custom CRISPR libraries for hypothesis-driven drug target discovery

por Iyer, Vaishnavi Srinivasan, Jiang, Long, Shen, Yunbing, Boddul, Sanjaykumar V., Panda, Sudeepta Kumar, Kasza, Zsolt, Schmierer, Bernhard, Wermeling, Fredrik
Publicado 2020

CRISPR/Cas9-Induced DNA Damage Enriches for Mutations in a p53-Linked Interactome: Implications for CRISPR-Based Therapies

por Jiang, Long, Ingelshed, Katrine, Shen, Yunbing, Boddul, Sanjaykumar V., Iyer, Vaishnavi Srinivasan, Kasza, Zsolt, Sedimbi, Saikiran, Lane, David P., Wermeling, Fredrik
Publicado 2022

IL-4 controls activated neutrophil FcγR2b expression and migration into inflamed joints

por Panda, Sudeepta Kumar, Wigerblad, Gustaf, Jiang, Long, Jiménez-Andrade, Yanek, Iyer, Vaishnavi Srinivasan, Shen, Yunbing, Boddul, Sanjaykumar V., Guerreiro-Cacais, André Ortlieb, Raposo, Bruno, Kasza, Zsolt, Wermeling, Fredrik
Publicado 2020

In vitro and ex vivo functional characterization of human HLA-DRB1∗04 restricted T cell receptors

por Boddul, Sanjaykumar V., Sharma, Ravi Kumar, Dubnovitsky, Anatoly, Raposo, Bruno, Gerstner, Christina, Shen, Yunbing, Iyer, Vaishnavi Srinivasan, Kasza, Zsolt, Kwok, William W., Winkler, Aaron R., Klareskog, Lars, Malmström, Vivianne, Bettini, Maria, Wermeling, Fredrik
Publicado 2021